Skip to main content
logo
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.430
-0.110 (-4.33%)
At close: Aug 28, 2026, 4:00 PM EDT
2.430
-0.001 (-0.02%)
After-hours: Aug 28, 2026, 7:48 PM EDT

Fate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2911131883699805,587
Market Cap Growth
125.36%-39.69%-49.04%-62.39%-82.45%-29.57%
Enterprise Value
213-23-101245865,018
Last Close Price
2.430.981.653.7410.0958.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
44.8617.0613.795.8010.18100.05
PB Ratio
1.850.550.591.002.038.23
P/TBV Ratio
1.900.550.591.002.038.23

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
32.83--1.956.0989.85

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.490.380.270.280.230.17
Net Debt / Equity Ratio
-0.51-0.61-0.61-0.57-0.67-0.74
Net Debt / EBITDA Ratio
0.650.941.101.231.112.37
Net Debt / FCF Ratio
0.741.121.571.531.152.35
Asset Turnover
0.020.020.030.110.120.07
Quick Ratio
4.755.697.398.134.177.70
Current Ratio
4.855.797.588.484.407.79
Return on Equity (ROE)
-60.75%-51.84%-54.21%-37.76%-48.46%-39.91%
Return on Assets (ROA)
-26.21%-24.12%-25.81%-19.65%-23.69%-17.57%
Return on Capital Employed (ROCE)
-58.20%-51.80%-48.60%-40.80%-52.10%-25.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-43.27%-120.27%-99.11%-43.64%-28.73%-3.80%
FCF Yield
-36.29%-98.85%-65.77%-37.53%-28.94%-3.82%
Buyback Yield / Dilution
-1.19%-4.49%-15.52%-1.64%-2.19%-15.00%
SEC Filings: 10-K · 10-Q